Susceptibility of Mycobacterium tuberculosis to first-line antimycobacterial agents in a Brazilian hospital: assessing the utility of the tetrazolium (MTT) microplate assay

• Main Authors: Michela De Luca Ferrari, Maria Alice da Silva Telles, Lucilaine Ferrazoli, Carlos Emílio Levy, Maria Cecília Barison Villares, Maria Luiza Moretti, Mariângela Ribeiro Resende
• Format: Article
• Language: English
• Published: Instituto Oswaldo Cruz, Ministério da Saúde 2010-08-01
• Series: Memórias do Instituto Oswaldo Cruz.
• Subjects: tuberculosis; resistance; drug susceptibility test; tetrazolium; colourimetric method; hospital
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000500010
• ISSN: 0074-0276; 1678-8060

We conducted a cross-sectional, hospital-based study between January 2006-March 2008 to estimate the resistance of Mycobacterium tuberculosis to first-line drugs in patients with tuberculosis at a Brazilian hospital. We evaluated the performance of the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide] (MTT) microplate assay compared with the Bactec-MGIT 960™ system for mycobacteria testing. The prevalence of resistance in M. tuberculosis was 6.7%. Multidrug-resistance [resistance to rifampicin (RMP) and isoniazid (INH)], INH-resistance and streptomycin (SM)-resistance accounted for 1%, 3.8% and 3.8% of all resistance, respectively, and all isolates were susceptible to ethambutol (EM). The resistance was primary in four cases and acquired in three cases and previous treatment was associated with resistance (p = 0.0129). Among the 119 M. tuberculosis isolates, complete concordance of the results for INH and EM was observed between the MTT microplate and Bactec-MGIT 960TM methods. The observed agreement for RMP was 99% (sensitivity: 90%) and 95.8% for SM (sensitivity 90.9%), lower than those for other drugs. The MTT colourimetric method is an accurate, simple and low-cost alternative in settings with limited resources.